← Back

Wire · regulatory

Trump picks Dr. Heidi Overton, a top White House aide, to lead the Food and Drug Administration

Published

19 August 2026

Topic

regulatory

Sectors

Health

Geography

United States

Source

Read at abc7ny.com

Verified

Fusion42 · 20 August 2026 · Fusion42 review

Dr. Heidi Overton, a close White House aide and medical doctor, has been nominated by President Trump to lead the FDA, facing challenges balancing drug pricing reforms, vaccine controversies, and regulatory shifts influenced by Health Secretary Robert F. Kennedy Jr. Her nomination signals potential rollbacks on abortion pill rules and a continuation of the administration's health priorities.

This Wire brief sits within Fusion42's coverage of Health, and 8 sources have reported it.

◆ The Wire takeaway

Your market access in digital health and biotech faces direct impact as FDA leadership shifts towards deregulation and policies favouring lower drug prices and more restrictive abortion pill oversight under Overton.

Coverage

8 sources · 19 Aug 2026

Topics

Healthfdahealth-regulationdrug-pricingvaccine-policyabortion-pilltrump-administration